TLA Technology: a new DNA diagnostic test to sequence genes that cause the disease and detect new mutations: proof of concept study voor patients with Rendu-Osler-Weber disease.

TLA Technology: a new DNA diagnostic test to sequence genes that cause the disease and detect new mutations: proof of concept study voor patients with Rendu-Osler-Weber disease. - ROW DNA test

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON39779

Enrollment

Registered

2013-03-28

Start date

2013-04-01

Completion date

Unknown

Last updated

2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rendu-Osler-Weber hereditary hemorrhagic telangiectasia

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patient with Rendu Osler Weber disease who didn't have a mutation tested in the previous testmethod Patients with known ENG or ALK mutation

Exclusion criteria

Exclusion criteria: Patients without ROW

Design outcomes

Primary

Measure	Time frame
See study objectives	—

Countries

Netherlands

Outcome results